Feed ORINY
OR

Orion Oyj ORINY · OTC

$53.25 +4.56% (+$2.32)

Market cap
24.8B €
Enterprise value
24.8B €
P/E
42.2x
Forward P/E
19.2x
PEG
1.1x
P/S
12.1x
P/FCF
64.4x
EV/EBITDA
31.6x
ROIC
40.6%
Gross margin
65.9%
Net margin
28.5%
Dividend yield
2.07%
Payout ratio
87.2%
Net debt/EBITDA
0.0x
Beta
0.29
Free float
44.0%

About the company

Orion Oyj is a Finnish pharmaceutical company headquartered in Espoo, focused on the research, development, manufacturing, and distribution of medicines and healthcare products. The company specializes in treatments for neurological and respiratory diseases, oncology, and urological disorders, while also offering a wide range of generic medicines and veterinary products. Orion operates not only in Finland but also internationally, in collaboration with various global partners. The company is recognized for its long-standing scientific heritage, high-quality standards, and strong focus on innovations that enhance patients’ quality of life.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Aino Anna Liisa Hurme

Employees

4,029

Headquarters

Espoo

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.